Literature DB >> 19052914

Amino acids in CSF and plasma in hyperammonaemic coma due to arginase1 deficiency.

S Scholl-Bürgi1, S Baumgartner Sigl, J Häberle, E Haberlandt, K Rostásy, C Ertl, U Eichinger-Öttl, P Heinz-Erian, D Karall.   

Abstract

UNLABELLED: We report the CSF and plasma amino acid concentrations and their ratios in a male patient with arginase1 deficiency with an unusual early presentation at 34 days of age. He developed hyperammonaemic coma (ammonia >400 μmol/L; normal <90 μmol/L) on postnatal day 35. CSF and plasma concentrations were assayed by ion-exchange chromatography on day 36. Arginine was increased both in plasma (971 μmol/L; controls (mean ± 2SD) 50 ± 42) and in CSF (157 μmol/L; controls 19 ± 8.6), resulting in a normal CSF/plasma ratio of 0.16 (controls 0.41 ± 0.26). Interestingly, glutamine was disproportionately high in CSF (3114 μmol/L; controls 470 ± 236) but normal in plasma (420 μmol/L; controls 627 ± 246); the ratio exceeded unity (7.4; controls 0.76 ± 0.31). The CSF/plasma ratios of most neutral amino acids were elevated but not those of the imino- and of the dibasic amino acids lysine and ornithine. The mechanism leading to the increase of most neutral amino acids in brain is not known.
CONCLUSION: A normal glutamine in plasma does not exclude an increased concentration in CSF; it could be useful to ascertain by MRS that a high CSF glutamine concentration truly reflects a high concentration in brain tissue for better understanding its pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19052914     DOI: 10.1007/s10545-008-0903-0

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  15 in total

Review 1.  Structural and functional aspects of the blood-brain barrier.

Authors:  David J Begley; Milton W Brightman
Journal:  Prog Drug Res       Date:  2003

2.  Hyperargininemia presenting as persistent neonatal jaundice and hepatic cirrhosis.

Authors:  A C Braga; L Vilarinho; E Ferreira; H Rocha
Journal:  J Pediatr Gastroenterol Nutr       Date:  1997-02       Impact factor: 2.839

3.  Fine structural localization of glutamine synthetase in astrocytes of rat brain.

Authors:  M D Norenberg; A Martinez-Hernandez
Journal:  Brain Res       Date:  1979-02-02       Impact factor: 3.252

4.  [Hyperargininemia wityh arginase deficiency. A new familial metabolic disease. I. Clinical studies].

Authors:  H G Terheggen; A Schwenk; A Lowenthal; M van Sande; J P Colombo
Journal:  Z Kinderheilkd       Date:  1970

Review 5.  Hyperargininemia due to liver arginase deficiency.

Authors:  Eric A Crombez; Stephen D Cederbaum
Journal:  Mol Genet Metab       Date:  2004-12-19       Impact factor: 4.797

6.  Arginase deficiency with lethal neonatal expression: evidence for the glutamine hypothesis of cerebral edema.

Authors:  Jonathan D Picker; Ana C Puga; Harvey L Levy; Deborah Marsden; Vivian E Shih; Umberto Degirolami; Keith L Ligon; Stephen D Cederbaum; Rita M Kern; Gerald F Cox
Journal:  J Pediatr       Date:  2003-03       Impact factor: 4.406

Review 7.  The human arginases and arginase deficiency.

Authors:  R Iyer; C P Jenkinson; J G Vockley; R M Kern; W W Grody; S Cederbaum
Journal:  J Inherit Metab Dis       Date:  1998       Impact factor: 4.982

Review 8.  Alternative pathway therapy for urea cycle disorders.

Authors:  F Feillet; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1998       Impact factor: 4.982

9.  [Hyperargininemia with arginase deficiency. A new familial metabolic disease. II. Biochemical studies].

Authors:  H G Terheggen; A Schwenk; A Lowenthal; M van Sande; J P Colombo
Journal:  Z Kinderheilkd       Date:  1970

10.  Amino acid cerebrospinal fluid/plasma ratios in children: influence of age, gender, and antiepileptic medication.

Authors:  Sabine Scholl-Bürgi; Edda Haberlandt; Peter Heinz-Erian; Florian Deisenhammer; Ursula Albrecht; Sara Baumgartner Sigl; Markus Rauchenzauner; Hanno Ulmer; Daniela Karall
Journal:  Pediatrics       Date:  2008-03-10       Impact factor: 7.124

View more
  9 in total

1.  Encephalopathy in acute liver failure resulting from acetaminophen intoxication: new observations with potential therapy.

Authors:  Saul W Brusilow; Arthur J L Cooper
Journal:  Crit Care Med       Date:  2011-11       Impact factor: 7.598

Review 2.  Arginase-1 deficiency.

Authors:  Yuan Yan Sin; Garrett Baron; Andreas Schulze; Colin D Funk
Journal:  J Mol Med (Berl)       Date:  2015-10-14       Impact factor: 4.599

3.  A Case of Hyperargininaemia Presenting at Unusually Low Age.

Authors:  Vanita Lal; Daisy Khera; Garima Gupta; Kuldeep Singh; Praveen Sharma
Journal:  J Clin Diagn Res       Date:  2017-07-01

4.  Arginase I deficiency: severe infantile presentation with hyperammonemia: more common than reported?

Authors:  Shailly Jain-Ghai; Sandesh C Sreenath Nagamani; Susan Blaser; Komudi Siriwardena; Annette Feigenbaum
Journal:  Mol Genet Metab       Date:  2011-07-13       Impact factor: 4.797

5.  Clinical phenotype, biochemical profile, and treatment in 19 patients with arginase 1 deficiency.

Authors:  Martina Huemer; Daniel R Carvalho; Jaime M Brum; Özlem Ünal; Turgay Coskun; James D Weisfeld-Adams; Nina L Schrager; Sabine Scholl-Bürgi; Andrea Schlune; Markus G Donner; Martin Hersberger; Claudio Gemperle; Brunhilde Riesner; Hanno Ulmer; Johannes Häberle; Daniela Karall
Journal:  J Inherit Metab Dis       Date:  2016-04-01       Impact factor: 4.982

Review 6.  Suggested guidelines for the diagnosis and management of urea cycle disorders.

Authors:  Johannes Häberle; Nathalie Boddaert; Alberto Burlina; Anupam Chakrapani; Marjorie Dixon; Martina Huemer; Daniela Karall; Diego Martinelli; Pablo Sanjurjo Crespo; René Santer; Aude Servais; Vassili Valayannopoulos; Martin Lindner; Vicente Rubio; Carlo Dionisi-Vici
Journal:  Orphanet J Rare Dis       Date:  2012-05-29       Impact factor: 4.123

7.  Modelling the Human Blood-Brain Barrier in Huntington Disease.

Authors:  Domenico Vignone; Odalys Gonzalez Paz; Ivan Fini; Antonella Cellucci; Giulio Auciello; Maria Rosaria Battista; Isabelle Gloaguen; Silvia Fortuni; Cristina Cariulo; Vinod Khetarpal; Celia Dominguez; Ignacio Muñoz-Sanjuán; Annalise Di Marco
Journal:  Int J Mol Sci       Date:  2022-07-15       Impact factor: 6.208

8.  Clinical effect and safety profile of pegzilarginase in patients with arginase 1 deficiency.

Authors:  George A Diaz; Andreas Schulze; Markey C McNutt; Elisa Leão-Teles; J Lawrence Merritt; Gregory M Enns; Spyros Batzios; Allison Bannick; Roberto T Zori; Leslie S Sloan; Susan L Potts; Gillian Bubb; Anthony G Quinn
Journal:  J Inherit Metab Dis       Date:  2021-01-26       Impact factor: 4.982

9.  Long-term outcomes in Ornithine Transcarbamylase deficiency: a series of 90 patients.

Authors:  Anais Brassier; Stephanie Gobin; Jean Baptiste Arnoux; Vassili Valayannopoulos; Florence Habarou; Manoelle Kossorotoff; Aude Servais; Valerie Barbier; Sandrine Dubois; Guy Touati; Robert Barouki; Fabrice Lesage; Laurent Dupic; Jean Paul Bonnefont; Chris Ottolenghi; Pascale De Lonlay
Journal:  Orphanet J Rare Dis       Date:  2015-05-10       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.